Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05132842 · ClinicalTrials.gov registry record
Cannabis Use Patterns Among Cancer Patients
A clinical trial, sponsored by Thomas Jefferson University.
- Completed
- Registry status
- 1,568
- Enrollment target
NCT05132842: Completed study, sponsored by Thomas Jefferson University.
NCT05132842 is a clinical trial that has completed, run by Thomas Jefferson University. The registered enrollment target is 1,568 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05132842 has completed, sponsored by Thomas Jefferson University.
- COMPLETED
- Registry status
- 1,568 participants
- Enrollment target
Study Summary
This study determines patterns of cannabis use among cancer patients. Information collected in this study may help doctors to understand patient use of cannabis therapy, their knowledge and experiences with this therapy, benefits and risks associated with its use, and whether or to what extent they are discussing it with their health care providers.
Primary Outcome
Respondent demographics and clinical characteristics and survey responses
Interventions
- OTHER Survey Administration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,568 participants |
| Start Date | 2021-02-25 |
| Est. Completion | 2022-10-29 |
What the finished NCT05132842 record still lists
NCT05132842 is an observational study that tracks outcomes without assigning an intervention. Its 1,568 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Survey Administration is the first listed.
NCT05132842 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05132842 about?
NCT05132842 is a clinical study titled "Cannabis Use Patterns Among Cancer Patients". This study determines patterns of cannabis use among cancer patients. Information collected in this study may help doctors to understand patient use of cannabis therapy, their knowledge and experiences with this therapy, benefits and risks associated with its use, and whether or to what extent they ...
What is the current status of trial NCT05132842?
This trial is currently completed. The enrollment target is 1,568 participants. The study started on 2021-02-25. Estimated completion is 2022-10-29.
What interventions are being tested in trial NCT05132842?
The interventions under investigation include: Survey Administration (OTHER).
Who is sponsoring clinical trial NCT05132842?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06034080 · 1,566 participants · NA
Interventions to De-implement Unnecessary Antibiotic Prescribing for Children With Ear Infections
- NCT06445946 · 1,572 participants · Phase 4
DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes
- NCT06881069 · 1,560 participants · NA
Reach Through Equitable Implementation in Utah
- NCT05483855 · 1,580 participants
Telehealth-delivered HealthcaRe to ImproVe Care
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI